ArticleFrontiers in public health2023

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile.

Diego A Díaz-Dinamarca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.